Secretory component mRNA and protein expression in colorectal adenomas and carcinomas
1996

Secretory Component mRNA and Protein Expression in Colorectal Adenomas and Carcinomas

Sample size: 52 publication Evidence: moderate

Author Information

Author(s): P Krajci, GI Meting, SN Andersen, B Hofstad, MH Vatn, TO Rognum, P Brandtzaeg

Primary Institution: University of Oslo

Hypothesis

The study investigates the relationship between secretory component mRNA and protein expression in colorectal adenomas and carcinomas.

Conclusion

Reduced secretory component protein expression in colorectal adenomas may reflect transcriptional defects, while absent expression in carcinomas may involve post-transcriptional defects.

Supporting Evidence

  • SC mRNA levels were positively related to SC protein expression in adenomas.
  • Reduced SC protein expression was associated with higher grades of dysplasia.
  • Only two of ten carcinomas lacked SC mRNA expression despite being SC deficient by immunohistochemistry.

Takeaway

This study looked at how a protein important for immunity behaves in certain types of colon tumors, finding that its levels change based on how severe the tumors are.

Methodology

The study used Northern blot analysis and immunohistochemistry to assess secretory component mRNA and protein levels in colorectal adenomas and carcinomas.

Limitations

The small sample size for some analyses limited the ability to draw strong conclusions.

Participant Demographics

The study included 31 patients with colorectal adenomas and 19 patients with colorectal carcinomas, with a mean age of 70 years for adenoma patients and 66 years for carcinoma patients.

Statistical Information

P-Value

p<0.01 for adenomas with severe dysplasia

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication